Loading...
Loading...
PureTech Health plc
PureTech Health plc. Spoken Alpha tracks PTCHF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PTCHF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PTCHF.
curl https://api.spokenalpha.com/v1/companies/PTCHF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $5.12 | $3.82 | +34.0% | +4.2% | +4.8% |
| Q4 FY2026 | $5.30 | $3.70 | +43.3% | -1.8% | -2.9% |
| Q3 FY2026 | $4.78 | $3.61 | +32.4% | -7.0% | -9.4% |
| Q2 FY2026 | $4.97 | $3.65 | +36.2% | -6.7% | -5.8% |
| Q1 FY2025 | $5.25 | $3.73 | +40.7% | -4.8% | -5.6% |
| Q4 FY2025 | $5.39 | $3.79 | +42.2% | +1.5% | -1.4% |
| Q3 FY2025 | $5.25 | $3.85 | +36.4% | -5.9% | -8.0% |
| Q2 FY2025 | $5.44 | $3.69 | +47.4% | -3.8% | -1.0% |
| Q1 FY2024 | $5.54 | $3.90 | +42.0% | +2.7% | +0.5% |
| Q4 FY2024 | $5.30 | $3.97 | +33.4% | -6.6% | -6.8% |